Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.

Accounting & Finance

Software Engineering

Other Engineering

People & HR

Product

Legal

Sales & Business Development

Operations

Data Science

Quality Assurance

United States

Menlo Park, CA, USA

San Francisco, CA, USA

North America

Grail

Alix Ventures

BIOS Community

Join TechBio Companies Driving Patient Impact